Your browser doesn't support javascript.
loading
State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015.
Lu, Christine Y; Zhang, Fang; Golonski, Nicole; Lupton, Caitlin; Jeffrey, Paul; Wagner, Anita K.
Affiliation
  • Lu CY; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA. Electronic address: christine_lu@harvardpilgrim.org.
  • Zhang F; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
  • Golonski N; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
  • Lupton C; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
  • Jeffrey P; MassHealth Office of Clinical Affairs, Quincy, MA; Department of Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, MA.
  • Wagner AK; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Value Health ; 21(6): 692-697, 2018 06.
Article in En | MEDLINE | ID: mdl-29909874
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Medicaid / Hepatitis C, Chronic / Insurance, Health, Reimbursement Type of study: Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Medicaid / Hepatitis C, Chronic / Insurance, Health, Reimbursement Type of study: Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2018 Type: Article